Maria Carmela Tartaglia

ORCID: 0000-0002-5944-8497
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Amyotrophic Lateral Sclerosis Research
  • Parkinson's Disease Mechanisms and Treatments
  • Traumatic Brain Injury Research
  • Advanced Neuroimaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Prion Diseases and Protein Misfolding
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Neurological Disease Mechanisms and Treatments
  • Cerebral Palsy and Movement Disorders
  • Systemic Lupus Erythematosus Research
  • Neurological diseases and metabolism
  • Cerebrospinal fluid and hydrocephalus
  • Neurological disorders and treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Multiple Sclerosis Research Studies
  • Genetic Neurodegenerative Diseases
  • Cardiac Arrest and Resuscitation
  • Advanced MRI Techniques and Applications
  • Neurogenetic and Muscular Disorders Research
  • Neurobiology of Language and Bilingualism
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Folate and B Vitamins Research
  • Health, Environment, Cognitive Aging

University of Toronto
2016-2025

University Health Network
2016-2025

Occupational Cancer Research Centre
2016-2025

Toronto Western Hospital
2016-2025

Ontario Brain Institute
2020-2025

Women's Brain Project
2020-2025

University of California, San Francisco
2009-2024

Discovery Centre
2015-2024

Munich Cluster for Systems Neurology
2024

Ludwig-Maximilians-Universität München
2022-2024

<h3>Objective</h3> To assess axonal damage and its contribution to disability at different stages of multiple sclerosis (MS). <h3>Background</h3> Recent in vivo imaging situ pathologic studies have demonstrated that substantial accompanies the inflammatory lesions MS. However, relation duration MS disease remain poorly defined. <h3>Design</h3> We performed proton magnetic resonance spectroscopic 88 patients with a wide range clinical measure<i>N</i>-acetylaspartate (NAA, an index integrity)...

10.1001/archneur.58.1.65 article EN Archives of Neurology 2001-01-01

Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about third of patients, the disease caused by autosomal dominant genetic mutations usually in one three genes: progranulin (GRN), microtubule-associated protein tau (MAPT), or chromosome 9 open reading frame 72 (C9orf72). Findings from studies other dementias have shown neuroimaging and cognitive changes before symptoms onset, we aimed to identify whether such could be frontotemporal dementia.

10.1016/s1474-4422(14)70324-2 article EN cc-by The Lancet Neurology 2015-02-04
Alexandra L. Young Răzvan V. Marinescu Neil P. Oxtoby Martina Bocchetta Keir Yong and 95 more Nicholas C. Firth David M. Cash David L. Thomas Katrina M. Dick M. Jorge Cardoso John C. van Swieten Barbara Borroni Daniela Galimberti Mario Masellis Maria Carmela Tartaglia James B. Rowe Caroline Graff Fabrizio Tagliavini Giovanni B. Frisoni Robert Laforce Elizabeth Finger Alexandre de Mendonça Sandro Sorbi Jason D. Warren Sebastian J. Crutch Nick C. Fox Sébastien Ourselin Jonathan M. Schott Jonathan D. Rohrer Daniel C. Alexander Christin Andersson Silvana Archetti Andrea Arighi Luisa Benussi Giuliano Binetti Sandra E. Black Maura Cosseddu Marie Fallström Carlos Ferreira Chiara Fenoglio Morris Freedman Giorgio Fumagalli Stefano Gazzina Roberta Ghidoni Marina Grisoli Vesna Jelić Lize C. Jiskoot Ron Keren Gemma Lombardi Carolina Maruta Lieke Meeter Simon Mead Rick van Minkelen Benedetta Nacmias Linn Öijerstedt Alessandro Padovani Jessica Panman Michela Pievani Cristina Polito Enrico Premi Sara Prioni Rosa Rademakers Veronica Redaelli Ekaterina Rogaeva Giacomina Rossi Martin N. Rossor Elio Scarpini David F. Tang‐Wai Håkan Thonberg Pietro Tiraboschi Ana Verdelho Michael W. Weiner Paul Aisen Ronald Petersen Clifford R. Jack William J. Jagust John Q. Trojanowki Arthur W. Toga Laurel Beckett Robert C. Green Andrew J. Saykin John C. Morris Leslie M. Shaw Zaven S. Khachaturian Greg Sorensen Lew Kuller Marc Raichle Steven M. Paul Peter Davies Howard Fillit Franz Hefti Davie Holtzman M. Marcel Mesulam William C. Potter Peter J. Snyder Adam Schwartz Tom Montine Ronald G. Thomas Michael Donohue Sarah Walter

Abstract The heterogeneity of neurodegenerative diseases is a key confound to disease understanding and treatment development, as study cohorts typically include multiple phenotypes on distinct trajectories. Here we introduce machine-learning technique—Subtype Stage Inference (SuStaIn)—able uncover data-driven with temporal progression patterns, from widely available cross-sectional patient studies. Results imaging studies in two reveal subgroups their trajectories regional...

10.1038/s41467-018-05892-0 article EN cc-by Nature Communications 2018-10-09

Primary progressive aphasia is a clinical syndrome that encompasses three major phenotypes: non-fluent/agrammatic, semantic and logopenic. These entities have been associated with characteristic patterns of focal grey matter atrophy in left posterior frontoinsular, anterior temporal temporoparietal regions, respectively. Recently, network-level dysfunction has hypothesized but research to date focused largely on studying damage. The aim this study was assess the integrity white tracts...

10.1093/brain/awr099 article EN Brain 2011-06-11

Accurately predicting the underlying neuropathological diagnosis in patients with behavioural variant frontotemporal dementia (bvFTD) poses a daunting challenge for clinicians but will be critical success of disease-modifying therapies. We sought to improve pathological prediction by exploring clinicopathological correlations large bvFTD cohort. Among 438 whom was either top or an alternative possible clinical diagnosis, 117 had available autopsy data, including 98 primary lobar degeneration...

10.1093/brain/awx254 article EN Brain 2017-09-11

We examined recovery from postconcussion syndrome (PCS) in a series of 285 patients diagnosed with concussion based on international sport criteria who received questionnaire regarding recovery. Of 141 respondents, those symptoms lasting less than 3 months, positive computed tomography (CT) and/or magnetic resonance imaging (MRI), litigants, and known Test Memory Malingering (TOMM)-positive cases were excluded, leaving 110 eligible respondents. found that only 27% our population eventually...

10.1089/neu.2016.4677 article EN Journal of Neurotrauma 2016-10-27

Abstract Objective To evaluate cerebrospinal fluid ( CSF ) and serum neurofilament light chain (NfL) levels in genetic frontotemporal dementia FTD as a potential biomarker the presymptomatic stage during conversion into symptomatic stage. Additionally, to correlate NfL clinical neuroimaging parameters. Methods In this multicenter case–control study, we investigated 174 subjects (48 controls, 40 carriers 86 patients with microtubule‐associated protein tau MAPT ), progranulin GRN chromosome 9...

10.1002/acn3.325 article EN cc-by Annals of Clinical and Translational Neurology 2016-07-01
Emma L. van der Ende Lieke Meeter Jackie M. Poos Jessica Panman Lize C. Jiskoot and 95 more Elise G.P. Dopper Janne M. Papma Frank Jan de Jong Inge M.W. Verberk Charlotte E. Teunissen Dimitris Rizopoulos Carolin Heller Rhian S. Convery Katrina Moore Martina Bocchetta Mollie Neason David M. Cash Barbara Borroni Daniela Galimberti Raquel Sánchez‐Valle Robert Laforce Fermín Moreno Matthis Synofzik Caroline Graff Mario Masellis Maria Carmela Tartaglia James B. Rowe Rik Vandenberghe Elizabeth Finger Fabrizio Tagliavini Alexandre de Mendonça Isabel Santana Christopher Butler Simon Ducharme Alexander Gerhard Adrian Danek Johannes Levin Markus Otto Giovanni B. Frisoni Stefano F. Cappa Yolande A.L. Pijnenburg Jonathan D. Rohrer John C. van Swieten Martin N. Rossor Jason D. Warren Nick C. Fox Ione Woollacott Rachelle Shafei Caroline Greaves Rita Guerreiro José Brás David L. Thomas Jennifer Nicholas Simon Mead Rick van Minkelen Myriam Barandiarán Begoña Indakoetxea Alazne Gabilondo Mikel Tainta María de Arriba Ana Gorostidi Miren Zulaica Jorge Villanúa Zigor Díaz Sergi Borrego‐Écija Jaume Olives Albert Lladó Mircea Balasa Anna Antonell Núria Bargalló Enrico Premi Maura Cosseddu Stefano Gazzina Alessandro Padovani Roberto Gasparotti Silvana Archetti Sandra E. Black Sara Mitchell Ekaterina Rogaeva Morris Freedman Ron Keren David F. Tang‐Wai Linn Öijerstedt Christin Andersson Vesna Jelić Håkan Thonberg Andrea Arighi Chiara Fenoglio Elio Scarpini Giorgio Fumagalli Thomas Cope Carolyn Timberlake Timothy Rittman Christen Shoesmith Robert Bartha Rosa Rademakers Carlo Wilke Hans‐Otto Karnath Benjamin Bender Rose Bruffaerts

10.1016/s1474-4422(19)30354-0 article EN The Lancet Neurology 2019-11-06

There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, known pathological process FTD, but has yet to be explored as potential biomarker.Plasma GFAP and neurofilament light chain (NfL) concentration were measured 469 individuals enrolled the Genetic FTD Initiative: 114 C9orf72 expansion carriers (74 presymptomatic, 40 symptomatic), 119 GRN mutation (88 31 53 MAPT (34 19 symptomatic) 183 non-carrier...

10.1136/jnnp-2019-321954 article EN Journal of Neurology Neurosurgery & Psychiatry 2020-01-14
Edmond Teng Paul T. Manser Karen Pickthorn Flávia Brunstein Mira Blendstrup and 95 more Sandra Sanabria Bohórquez Kristin R. Wildsmith Bali Toth Michael Dolton Vidya Ramakrishnan Ashwini Bobbala Sietske A.M. Sikkes Michael E. Ward Reina N. Fuji Geoffrey A. Kerchner Peter Farnbach Chris Kyndt Terence J. O’Brien Nawaf Yassi Raymond Schwartz Siddhartha Lieten Rik Vandenberghe F. Vanhee Richard Bergeron Sandra E. Black Sharon Cohen Andrew Frank William Nisker Maria Carmela Tartaglia Annette Justesen Peter Alexandersen Søren Nielsen A. Areovimata Pierre Anthony Serge Belliard Frédéric Blanc Mathieu Ceccaldi Bruno Dubois Pierre Krolak‐Salmon Hélène Mollion Florence Pasquier Timo Grimmer Monika Elisabeth Kottke-Arbeiter Christoph Laske Oliver Peters D Polívka Christine A. F. Von Arnim Giuseppe Bruno Carlo de Lena Emanuele Cassetta Diego Centonze Giancarlo Logroscino P. L. J. Dautzenberg Sterre Malou Rutgers Niels D. Prins Maciej Czarnecki Jacek Dobryniewski Jan Ilkowski Gabriela Klodowska Anna Krygowska‐Wajs Robert Kucharski Anatol Mickielewicz Marcin Ratajczak Marzena Zboch Tomasz Zieliński Pedro Abizanda Eduardo Agüera Miquel Baquero Toledo Rafael Blesa González Merçé Boada Antonio Del Olmo Rodriguez Jerzy Krupiński Gurutz Linazasoro Cristóbal Jesus Arrieta Mario Riverol Fernandez Raquel Sanchez Del Valle Diaz Félix Viñuela Fernandez Michael Jonsson Henrik Östlund Josephine Emer MacSweeney Catherine J. Mummery Marc Agronin A. Thomas Wendy Bond Frederick W. Schaerf Mark Brody Keith R. Edwards Concetta Forchetti Anil K. Sood David Geldmacher Larry B. Goldstein Ira Goodman David Hart Lawrence S. Honig William Justiz Allan I. Levey Scott Losk Gad A. Marshall Walter Martínez Peter McAllister

<h3>Importance</h3> Neurofibrillary tangles composed of aggregated tau protein are one the neuropathological hallmarks Alzheimer disease (AD) and correlate with clinical severity. Monoclonal antibodies targeting may have potential to ameliorate AD progression by slowing or stopping spread and/or accumulation pathological tau. <h3>Objective</h3> To evaluate safety efficacy monoclonal anti-tau antibody semorinemab in prodromal mild AD. <h3>Design, Setting, Participants</h3> This phase 2...

10.1001/jamaneurol.2022.1375 article EN cc-by-nc-nd JAMA Neurology 2022-06-13
Adam M. Staffaroni Melanie Quintana Barbara Wendelberger Hilary W. Heuer Lucy L. Russell and 95 more Yann Cobigo Amy Wolf Sheng‐Yang M. Goh Leonard Petrucelli Tania F. Gendron Carolin Heller Annie L Clark Jack C. Taylor Amy B. Wise Elise Ong Leah K. Forsberg Danielle Brushaber Julio C. Rojas Lawren VandeVrede Peter A. Ljubenkov Joel H. Kramer Kaitlin B. Casaletto Brian S. Appleby Yvette Bordelon Hugo Botha Bradford C. Dickerson Kimiko Domoto‐Reilly Julie A. Fields Tatiana Foroud Ralitza H. Gavrilova Daniel H. Geschwind Nupur Ghoshal Jill Goldman Jonathon Graff-Radford Neill R. Graff‐Radford Murray Grossman Matthew Hall Ging‐Yuek Robin Hsiung Edward D. Huey David J. Irwin David T. Jones Kejal Kantarci Daniel Kaufer David S. Knopman Walter K. Kremers Argentina Lario Lago Maria I. Lapid Irene Litvan Diane Lucente Ian R. Mackenzie Mario F. Mendez Carly T. Mester Bruce L. Miller Chiadi U. Onyike Rosa Rademakers Vijay K. Ramanan Eliana Marisa Ramos Meghana Rao Katya Rascovsky Katherine P. Rankin Erik D. Roberson Rodolfo Savica Maria Carmela Tartaglia Sandra Weıntraub Bonnie Wong David M. Cash Arabella Bouzigues Imogen J. Swift Georgia Peakman Martina Bocchetta Emily Todd Rhian S. Convery James B. Rowe Barbara Borroni Daniela Galimberti Pietro Tiraboschi Mario Masellis Elizabeth Finger John C. van Swieten Harro Seelaar Lize C. Jiskoot Sandro Sorbi Christopher Butler Caroline Graff Alexander Gerhard Tobias Langheinrich Robert Laforce Raquel Sánchez‐Valle Alexandre de Mendonça Fermín Moreno Matthis Synofzik Rik Vandenberghe Simon Ducharme Isabelle Le Ber Johannes Levin Adrian Danek Markus Otto Florence Pasquier Isabel Santana John Kornak

10.1038/s41591-022-01942-9 article EN Nature Medicine 2022-09-22

<h3>Background</h3> Fatigue is a common and distressing symptom for patients with multiple sclerosis (MS). There growing evidence that fatigue in MS has central nervous system component. We hypothesized diffuse cerebral axonal damage could be associated used proton magnetic resonance spectroscopy to noninvasively measure or loss the brains of MS. <h3>Objective</h3> To assess strength relationship between brain<i>N</i>-acetylaspartate fatigue. <h3>Design</h3> Data from 73 who had undergone...

10.1001/archneur.61.2.201 article EN Archives of Neurology 2004-02-01

Background: Although in situ pathological studies and vivo magnetic resonance (MR) investigations have shown that axonal injury can be significant the early stages of multiple sclerosis (MS), diffuse is generally considered a secondary event.Cerebral damage specifically assessed by measuring levels brain N-acetylaspartate (NAA, specific index integrity detected MR spectroscopy).Other new measurements such as magnetization transfer ratio (MTr) or computed estimation volume provide less...

10.1001/archneur.59.10.1565 article EN Archives of Neurology 2002-10-01

Frontotemporal dementia (FTD) is a highly heritable condition with multiple genetic causes. In this study, similarities and differences of gray matter (GM) atrophy patterns were assessed among 3 common forms FTD (mutations in C9orf72, GRN, MAPT). Participants from the Genetic Initiative (GENFI) cohort suitable volumetric T1 magnetic resonance imaging scan included (319): 144 nonmutation carriers, 128 presymptomatic mutation 47 clinically affected carriers. Cross-sectional GM volume between...

10.1016/j.neurobiolaging.2017.10.008 article EN cc-by Neurobiology of Aging 2017-10-19

Clinical diagnosis of Alzheimer's disease (AD) prior to the age 65 years is classified as young-onset (YOAD), whereas after considered late-onset (LOAD). Although rare autosomal mutations more commonly associate with YOAD, most YOAD and LOAD cases are sporadic. share amyloid tau pathology, but many patients show increased severity rate progression. The current study examined microRNA (miRNA) expression profile from exosomes isolated cerebrospinal fluid (CSF) biomarker-confirmed AD. Results...

10.1007/s12035-018-1032-x article EN cc-by Molecular Neurobiology 2018-03-30

Chronic traumatic encephalopathy (CTE) is the term coined for neurodegenerative disease often suspected in athletes with histories of repeated concussion and progressive dementia. Histologically, CTE defined as a tauopathy distribution tau-positive neurofibrillary tangles (NFTs) that distinct from other tauopathies, usually shows an absence beta-amyloid deposits, contrast to Alzheimer's (AD). Although connection between concussions CTE-type neurodegeneration has been recently proposed, this...

10.3389/fnhum.2013.00222 article EN cc-by Frontiers in Human Neuroscience 2013-01-01

OBJECTIVE The objective of this study was to determine the demographics and predictors postconcussion syndrome (PCS) in a large series patients using novel definition PCS. METHODS authors conducted retrospective cohort 284 consecutive concussed patients, 221 whom had PCS on basis at least 3 symptoms persisting 1 month. This uniformly employed is unique accepting an expanded list symptoms, shortening interval month from months, excluding those with focal injuries such as hemorrhages...

10.3171/2015.6.jns15664 article EN Journal of neurosurgery 2016-02-26

Transactive response DNA-binding protein 43 (TDP-43) is a major pathological in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). There are many disease-associated mutations TDP-43, several cellular animal models with ectopic overexpression of mutant TDP-43 have been established. Here we sought to study altered molecular events FTD ALS by using induced pluripotent stem cell (iPSC) derived patient neurons. We generated multiple iPSC lines from an FTD/ALS the TARDBP A90V...

10.1371/journal.pone.0076055 article EN cc-by PLoS ONE 2013-10-15

The pathogenic mechanisms of frontotemporal dementia (FTD) remain poorly understood. Here we generated multiple induced pluripotent stem cell lines from a control subject, patient with sporadic FTD, and an FTD novel heterozygous GRN mutation (progranulin [PGRN] S116X). In neurons microglia differentiated PGRN S116X cells, the levels intracellular secreted were reduced, establishing patient-specific cellular models haploinsufficiency. Through systematic screen inducers stress, found that...

10.1016/j.celrep.2012.09.007 article EN cc-by Cell Reports 2012-10-01

<h3>Background</h3> Elevated CSF τ is considered a biomarker of neuronal injury in newly developed Alzheimer9s disease (AD) and mild cognitive impairment (MCI) criteria. However, previous studies have failed to detect alterations species other primary tauopathies. We assessed protein abnormalities AD, tauopathy with prominent Aβ pathology, progressive supranuclear palsy (PSP), characterised by deposition four microtubule-binding repeat (4R) minimal pathology. <h3>Methods</h3> 26 normal...

10.1136/jnnp-2014-308004 article EN Journal of Neurology Neurosurgery & Psychiatry 2014-06-04

The frontotemporal cortical network is associated with behaviours such as impulsivity and aggression. health of the uncinate fasciculus (UF) that connects orbitofrontal cortex (OFC) anterior temporal lobe (ATL) may be a crucial determinant behavioural regulation. Behavioural changes can emerge after repeated concussion thus we used MRI to examine UF connected gray matter it relates aggression in retired professional football players who had sustained multiple concussions. Behaviourally,...

10.1007/s00429-015-1012-0 article EN cc-by Brain Structure and Function 2015-02-26
Coming Soon ...